Navigation Links
TrialNetworks Sees Strong Growth in Demand for its Clinical Trial Optimization System as Pharma Seeks Technology to Improve Operations Quality and Efficiency
Date:11/7/2013

Needham, MA (PRWEB) November 07, 2013

TrialNetworks provides clinical trial sponsors and CROs with the industry’s only Clinical Trial Optimization System used to improve the quality and efficiency of study operations from startup through closeout. The company has seen rapid growth in demand for its technology as pharma companies have become increasingly aware of the innovative technology and the proven benefits it provides for global feasibility, site activation, patient recruitment, patient retention, site engagement, trial conduct and more.

During Q3 2013, the TrialNetworks platform was implemented for use on more trials than all of 2012. The company attributes this significant growth to three key factors:

  • Proven Value: Due to the real-world improvements experienced by customers using TrialNetworks for the first time, nearly every sponsor that implemented the TrialNetworks platform for a single trial subsequently added additional trials.
  • Market Awareness: Over time, more companies are gaining exposure to the innovative system, often through published articles, case studies and conferences where its benefits are being presented by existing customers.
  • New Apps and Exclusive Features: TrialNetworks continually works with clients to understand requirements and develop new apps and features to fulfill unmet needs, such as Survey™ for feasibility assessments, Directory™ for trial contact management and Checklist™ for efficient site startup and closeout.
Additional milestones achieved by TrialNetworks in Q3 2013 included:
  • 30% growth in employees to support increased demand
  • 25,000th person logged onto the Clinical Trial Optimization System
  • Coverage of the TrialNetworks platform in '/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. TrialNetworks Feasibility Survey™ App Gets ARIAD Pharmaceuticals Unprecedented 75% Response from Potential Clinical Trial Investigator Sites
2. TrialNetworks Customer to Present Results of Using Site Engagement Technology to Improve Study Operations and Patient Enrollment at Clinical Trial Optimization Conference
3. Terascala Closes Additional Funding Based on Strong OEM Sales and Release of ISB
4. Shire plc: Strong Third Quarter and Increased Non GAAP Earnings Expectations
5. New SPIE Open Access Publishing Program Wins Strong Participation
6. Industries Show Strong Support for 2B Monthly-The Global Biocontrol & Biostimulants Newsletter
7. California Physical Therapy Association Strongly Supports the "Promoting Integrity in Medicare Act" to Fight Self-Referral of Physical Therapist Services
8. Global Pain Management Therapeutics Market to 2019 - Impact of Patent Expiries Offset by Demand for Neuropathic and Rheumatoid Pain Medications and Strong Pipeline: MarketResearchReports.Biz
9. Bed Bugs Bum Rides on Taxis, Use of Non-Pesticide Bed Bug Spray Recommended by My Cleaning Products to Kill the Pests Without Strong Chemicals' Help
10. UNL teams discovery yields supertough, strong nanofibers
11. NW Bio 2012 Annual Report Shows Strong Progress And Enhancement Of Leadership Position
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Canada (PRWEB) January 15, 2014 This ... on nonclinical and clinical safety assessment in biosimilars. , ... path for biosimilar drug development, however the complex nature ... to quality, safety and efficacy extremely challenging. Based on ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how ... latent viruses is the Epstein Barr Virus (EBV), and one ... is a chronic inflammatory disease that destroys the body’s joints. ... patients have high concentrations of EBV DNA in their bodies ...
(Date:1/15/2014)... ON (PRWEB) January 15, 2014 AudioNotch ... experimental new therapy for the treatment of tinnitus. Patients ... tinnitus frequency, and over a period of weeks to months, ... Sound Therapy in two forms: Notched Music and Notched White ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... the leading management consulting firm specializing in the pharmaceutical ... industry veterans Jon W. McGarity and David Lilley as ... with John Campbell, CEO of Campbell Alliance, and the ... and midsize client companies. They will focus on ...
... for Discovery and Validation of New Biomarker Panels ... Rules-Based Medicine, Incorporated (RBM), the world,s leading multiplexed ... the most comprehensive collection of quantitative immunoassays for ... drug and diagnostic development. The new service, DiscoveryMAP(TM) ...
... REGENSBURG, Germany, June 17 , - ... Reproductive Medicine , - MedITEX from 28 ... 87/88) , The IT consulting company CRITEX, ... for in vitro fertilisation, MedITEX IVF,at the 25th Annual Meeting of ...
Cached Biology Technology:Campbell Alliance Adds Industry Veterans Jon W. McGarity and David Lilley as Executive Vice Presidents 2Campbell Alliance Adds Industry Veterans Jon W. McGarity and David Lilley as Executive Vice Presidents 3Campbell Alliance Adds Industry Veterans Jon W. McGarity and David Lilley as Executive Vice Presidents 4Rules-Based Medicine, Inc. Launches DiscoveryMAP(TM) Service for Drug and Diagnostic Development 2Rules-Based Medicine, Inc. Launches DiscoveryMAP(TM) Service for Drug and Diagnostic Development 3New IVF Software MedITEX to be Presented at the ESHRE Exhibition 2
(Date:4/22/2014)... team of Yale researchers will lead a five-year, $3 ... rain events is affecting the transport of dissolved organic ... they say could alter the chemical composition and water ... With funding from the National Science Foundation,s MacroSystems Biology ... across the watershed, which begins in Canada and runs ...
(Date:4/22/2014)... 2014) Biotechnology scientists must be aware of the ... licensing guidelines, according to a new paper from Rice ... the current issue of the journal Regenerative Medicine ... U.S. Supreme Court ruling in the case Association for ... genes are unpatentable. The court case and rulings garnered ...
(Date:4/22/2014)... University of Massachusetts Amherst and the Instituto Nacional de ... they have discovered a new genus and species of ... in the Amazonia State of Brazil. , Professor Cristina ... Jos Antnio Alves-Gomes of INPA, describe the new bluntnose ... Proceedings of the Natural Sciences of Philadelphia . ...
Breaking Biology News(10 mins):Connecticut River watershed study will assess impacts of extreme rain events 2Connecticut River watershed study will assess impacts of extreme rain events 3New patenting guidelines are needed for biotechnology 2New patenting guidelines are needed for biotechnology 3New electric fish genus and species discovered in Brazil's Rio Negro 2
... continued support of the Colorado BioScience Association today, ... showcase event in Colorado to be held at the ... in the goals and community that is fostered by the ... of BiOptix.   "As Colorado continues to expand its footprint ...
... way to prevent inflammation and bone loss surrounding the ... enzyme GSK3b, which plays an important role in directing ... School of Dentistry researcher David Scott, PhD, and his ... Molecular Medicine . The finding not only has implications ...
... PORTLAND, Ore. A novel human liver-chimeric mouse model developed ... made possible a research breakthrough at Seattle Biomedical Research Institute ... of human malaria. The study findings are published ... photos were selected to appear in "Scientific Show Stoppers" on ...
Cached Biology News:BiOptix Participates in Leading Life Sciences Event BioWest 2012 2'Humanized' mice developed at OHSU enable malaria research breakthrough at Seattle BioMed 2'Humanized' mice developed at OHSU enable malaria research breakthrough at Seattle BioMed 3
... Yeast ProtoArray high-density functional protein microarray is ... elucidation of proteinprotein interactions on a proteome ... cerevisiae open reading frames (ORFs) expressed as ... on a 1 inch x 3 inch ...
... is a compact, versatile system that simultaneously ... or 24-well microplates into a solid filter ... scintillation and gamma counter. The FilterMate is ... applications such as cell proliferation, receptor binding, ...
... Corning single use spatulas have been designed ... They are for those interested in eliminating ... spatulas. Each spatula is individually packaged, RNase/DNase ... number is a new product number, created ...
... Competitor Assay Kits are ideal for ... binding compounds using fluorescence polarization (FP) ... of glutathione transferase to the ligand ... [PR-LBD(GST)] and a proprietary, fluorescently-tagged progesterone ...
Biology Products: